- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT05380817
Stanford Kids CAMP Study
Stanford Kids Continuous Advanced Metabolic Profiling (CAMP) Study
연구 개요
상세 설명
The proposed study is an outpatient prospective, open-label clinical trial comparing 2 groups: Group 1 (aka BAWSI Camp): the Dexcom G6 Pro Continuous Glucose Monitor and the accelerometer and mobile connected device, Group 2 (aka YMCA of Silicon Valley Camp): the Abbott FreeStyle Libre 2 Continuous Glucose Monitor and the accelerometer and mobile connected device. Eligible subjects will be enrolled to each cohort based on their participation in the specific YMCA camp site.
The investigators will study up to 100 minority school-age children (5 - 13 years old) in the San Francisco Bay Area a 5-day summer camp. The study will be split in 2 sequential phases: (A) the BAWSI camp, (B) the YMCA of Silicon Valley camp, following a repeated measures design with the 5-day camp being followed by 5 - 9 days at home, under parental supervision. Study participants will be divided in two equal groups at each site with each wearing the specific manufacturers continuous glucose monitoring device.
연구 유형
등록 (예상)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Grant S Wells, MS
- 전화번호: (650) 723-7632
- 이메일: gwells2@stanford.edu
연구 장소
-
-
California
-
Stanford, California, 미국, 94305
- Stanford University
-
연락하다:
- Grant S Wells, MS
- 전화번호: 650-723-7632
- 이메일: gwells2@stanford.edu
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- 5-13 years of age.
- Avoidance of acetaminophen-containing medications (i.e. Tylenol) while wearing the continuous glucose monitor.
- Willingness to wear a continuous glucose sensor and physiological monitor for the duration of the study.
- A parent/caregiver is available for system training and will commit to be the main responsible person for the use of the monitoring system at home.
Exclusion Criteria:
- Have a condition limiting their participation in the interventions (e.g., unable to participate in routine physical education classes at school, requiring oxygen supplementation for exertion, developmental or physical disability preventing participation in interventions, children or parents/guardians who cannot medically participate in mild dietary restrictions and/or increased physical activity for any reason).
- Have a condition limiting participation in the assessments (child or primary caregiver not able to read surveys in English or Spanish, child two or more grade levels delayed in school for reading and writing in her native language).
- Are unable to read, understand or complete informed consent in English or Spanish.
- Are deemed to have another characteristic that makes them unsuitable for participation in the study in the judgment of the Principal Investigators.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 다른
- 할당: 무작위화되지 않음
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
다른: BAWSI Group
By partnering with a community sports club (BAWSI), will the partnership recruitment model be effective in enrolling minority children.
|
Participants receive remote monitoring while engaging in a theory-based, multi-component, multi-level, multi-setting (MMM) community team sports program designed specifically for children
|
|
다른: YMCA of Silicon Valley Group
By partnering with a community organization (YMCA of Silicon Valley), will the partnership recruitment model be effective in enrolling minority children.
|
Participants receive remote monitoring while engaging in a theory-based, multi-component, multi-level, multi-setting (MMM) community team sports program designed specifically for children
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Percentage of underrepresented minority participants enrolled
기간: Baseline (prior to arrival at camp)
|
Percentage of underrepresented minority participants enrolled compared to the U.S. national average.
|
Baseline (prior to arrival at camp)
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Duration of initial participant screening
기간: Visit 1 (day 1, up to 60 minutes for screening)
|
Average duration of time to screen enrolled subjects on Day 1 of summer camp.
|
Visit 1 (day 1, up to 60 minutes for screening)
|
|
Report of issues and concerns during at-home monitoring period
기간: Visit 4, Visit 6 (days 6 and 14, up to 30 minutes to complete survey)
|
# of telephone reported incidents and questions during at-home monitoring period.
|
Visit 4, Visit 6 (days 6 and 14, up to 30 minutes to complete survey)
|
|
Physical activity measured by accelerometry
기간: Baseline through Visit 6 (days 1 through 14)
|
Garmin Vivofit 4 total and after camp physical activity and sedentary behavior
|
Baseline through Visit 6 (days 1 through 14)
|
|
Participant perceived use of study technology
기간: Visit 6 (day 14, up to 15 minutes to complete survey)
|
Percentage of survey responses
|
Visit 6 (day 14, up to 15 minutes to complete survey)
|
|
At-home urine specimen collection
기간: Visit 1, Visit 3 (collected on days 1 and 5)
|
Percentage of enrolled participants who complete at home urine sample collection and bring the sample with them to camp.
|
Visit 1, Visit 3 (collected on days 1 and 5)
|
|
Continuous patient monitoring performance
기간: Baseline through Visit 6 (days 1 though 14)
|
Percentage of total study time children were monitored using glucose and accelerometry devices
|
Baseline through Visit 6 (days 1 though 14)
|
|
Number of patient reported device related issues
기간: Visit 1, Visit 2, Visit 3 (days 1 though 5)
|
This measure is intended to evaluate study device performance during summer camp
|
Visit 1, Visit 2, Visit 3 (days 1 though 5)
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Karl Sylvester, MD, Stanford University
연구 기록 날짜
연구 주요 날짜
연구 시작 (예상)
기본 완료 (예상)
연구 완료 (예상)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
IPD 공유 기간
IPD 공유 지원 정보 유형
- 연구 프로토콜
- 통계 분석 계획(SAP)
- 정보에 입각한 동의서(ICF)
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
미국에서 제조되어 미국에서 수출되는 제품
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .